Catalyst Wire Dossier Catalyst Wire Dossier

PRX019

· Prothena Biosciences Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRX019, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of PRX019 in Healthy Adult Volunteers [Phase 1]

See pricing